EBCLIS on Rich On Tech

Rich On TechMay 30, 2026

Roku’s new home screen, Meta subscriptions & AI phishing scams (176, May 30, 2026)

0:37
mid-roll
Rich DeMuro
May 30, 2026
UnknownBrand awarenessBaked-in adSaaS
0:00 / 0:37
@ 82:03 in ep

Estimated current placement value

Low confidence
~$240range $36$1,700

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 2,000 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 0:37 · Unknown · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

EMBKLESS, labrikizumab, LBKZ, a two hundred fifty milligram per two milliliter injection is a prescription medicine used to treat adults and children 12 years of age and older who weigh at least eighty eight pounds or forty kilograms with moderate to severe eczema, also called atopic dermatitis that is not well controlled with prescription therapies used on the skin or topicals or who cannot use topical therapies. EBCLIS can be used with or without topical corticosteroids. Don't use if you're allergic to EBCLIS. Allergic reactions can occur that can be severe. Eye problems can occur. Tell your doctor if you have new or worsening eye problems. You should not receive a live vaccine when treated with EBCLIS. Before starting EBCLIS, tell your doctor if you have a parasitic infection.

Auto-transcribed · verbatim audio matches · Report an error

Episode

Rich On Tech
Roku’s new home screen, Meta subscriptions & AI phishing scams (176, May 30, 2026)
Host: Rich DeMuro